Furosemide for prevention of morbidity in indomethacin‐treated infants with patent ductus arteriosus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Furosemide for Prevention of Morbidity in Indomethacin‐treated Infants With Patent Ductus Arteriosus." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431583/all/images/ios-appstore-badge.png. Accessed 27 April 2024.
Furosemide for prevention of morbidity in indomethacin‐treated infants with patent ductus arteriosus. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431583/all/images/ios-appstore-badge.png. Accessed April 27, 2024.
Furosemide for prevention of morbidity in indomethacin‐treated infants with patent ductus arteriosus. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431583/all/images/ios-appstore-badge.png
Furosemide for Prevention of Morbidity in Indomethacin‐treated Infants With Patent Ductus Arteriosus [Internet]. In: Cochrane Abstracts. [cited 2024 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431583/all/images/ios-appstore-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Furosemide for prevention of morbidity in indomethacin‐treated infants with patent ductus arteriosus
ID - 431583
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431583/all/images/ios-appstore-badge.png
DB - Evidence Central
DP - Unbound Medicine
ER -